Figure 2From: Secondary cytoreduction surgery improves prognosis in platinum-sensitive recurrent ovarian cancer Symptomatic recurrent patients who underwent secondary CRS had shorter OS (A) and TTP (B) durations than asymptomatic ones (2A, 2B). Back to article page